sacituzumab govitecan
gilead sciences
['breast', 'sacituzumab']
#asco22 | poster 449 | mon 8:00am cdt
sacituzumab govitecan (sg) versus treatment of physician s choice (tpc) in patients (pts) with previously treated, metastatic triple-negative breast cancer....
presenter: aditya bardia, md ( ) 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.